Congenital Anomaly Screening Principles for Ob-Gyns | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Congenital Anomalies Screening Principles Every Ob-Gyn Must Know [ Medical Education ](https://mdster.com/blog?category=medical-education) Congenital Anomalies Screening Principles Every Ob-Gyn Must Know ================================================================== A high-yield guide to referral red flags, structural versus chromosomal thinking, and the timing logic behind anomaly screening [ MDster Editorial Team ](https://mdster.com/about) · May 05, 2026 · 6 min read · 28 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ Obstetrics ](https://mdster.com/blog?tag=obstetrics) [ Prenatal Diagnosis ](https://mdster.com/blog?tag=prenatal-diagnosis) [ Fetal Ultrasound ](https://mdster.com/blog?tag=fetal-ultrasound) [ Müllerian Anomalies ](https://mdster.com/blog?tag=mullerian-anomalies) ![Congenital Anomalies Screening Principles Every Ob-Gyn Must Know](https://mdster.com/storage/blog/images/congenital-anomalies-screening-principles-every-ob-gyn-must-know.jpg) Share this article Share this post Missed congenital anomalies are rarely missed because nobody ordered a test. They are missed because clinicians confuse a chromosomal screen with an anatomy screen, overcall a soft marker, or underreact to a true red flag. For boards and for practice, keep one rule in your head: a low-risk cfDNA result does **not** equal a structurally normal fetus. Every patient still needs imaging-based structural assessment, and any concerning ultrasound finding should change the conversation from reassurance to referral and possible diagnostic testing. [\[1\]](#cite-1 "Reference [1]") Start by separating structure from chromosomes ---------------------------------------------- Chromosomal screening answers a risk question; ultrasound answers an anatomy question. ACOG states that prenatal genetic screening and diagnostic testing should be offered to all pregnant patients, and that cfDNA is the most sensitive and specific screening test for the common aneuploidies. But it remains a **screen**, not a diagnosis, and it does not replace the second-trimester ultrasound because structural defects can occur with or without fetal aneuploidy. [\[2\]](#cite-2 "Reference [2]") That distinction matters when you see an ultrasound finding. A true **structural anomaly** is a morphologic defect: ventral wall defect, major heart defect, renal agenesis, megacystis, CNS malformation. A **soft marker** is different; it modifies aneuploidy risk but is not itself a major malformation. SMFM specifically advises against diagnostic testing solely for an isolated soft marker after negative serum or cfDNA screening, and several isolated markers need no further aneuploidy workup in that setting. Board trap: do not treat an isolated echogenic intracardiac focus like a cardiac defect. [\[3\]](#cite-3 "Reference [3]") Know the scan windows --------------------- Use a window-based mental model instead of memorizing isolated dates. The first-trimester scan at **11 to 14 weeks** is no longer just for dating and NT; ISUOG emphasizes that it is also an opportunity to assess fetal anatomy, and several severe anomalies may already be visible. Still, this is an early screen, not the final word. The routine mid-trimester scan remains the main structural survey. ACOG says patients should have at least one standard ultrasound, usually at **18 to 22 weeks**, and ISUOG places the routine mid-trimester anatomy scan at about **18 to 24 weeks** depending on technical factors and local practice. If diagnostic testing is needed, CVS is generally done at **10 to 13 weeks**, whereas amniocentesis is usually done at **15 to 20 weeks**; second-trimester serum screening such as AFP/quad is typically performed in the **15 to 22 week** range. [\[4\]](#cite-4 "Reference [4]") WindowBest useCommon pitfall11-14 weeksDating, NT, early structural survey, early risk stratificationAssuming a normal early scan excludes later structural disease18-22 weeks, conceptually up to 24 in some settingsMain detailed anatomy scanSkipping it because cfDNA was low risk10-13 weeks for CVS; 15-20 weeks for amnio; 15-22 weeks for serum screeningDiagnostic follow-up or biochemical screening when indicatedOrdering more screening when the patient now needs diagnosis The practical lesson is simple: **screen early when useful, but diagnose deliberately**. If ultrasound shows a structural problem, do not keep stacking screening tests and calling that management. [\[2\]](#cite-2 "Reference [2]") Red flags that should trigger referral now ------------------------------------------ Some findings should immediately raise the temperature in the room. ACOG is explicit: if there is an **enlarged nuchal translucency** or a fetal anomaly on ultrasound, offer genetic counseling and diagnostic testing, and arrange comprehensive ultrasound evaluation, including detailed ultrasonography at 18 to 22 weeks. A positive cfDNA result also needs counseling, detailed anatomic survey, and recommended confirmatory diagnostic testing rather than simple reassurance or repeat screening. [\[5\]](#cite-5 "Reference [5]") In day-to-day practice, refer when you see any major structural anomaly, more than one abnormal finding, abnormal screening plus abnormal imaging, or anatomy you cannot confidently complete. Organ-specific red flags matter too: ISUOG notes that an abnormally enlarged fetal bladder or persistent nonvisualization of the bladder should prompt detailed assessment, and ACOG notes that specialized ultrasound is indicated when a problem is suspected from risk factors or prior testing. [\[6\]](#cite-6 "Reference [6]") > **Clinical Pearl:** When anatomy and genetics disagree, believe the fetus first. A normal screening result never neutralizes a real structural abnormality. Müllerian development: think across systems ------------------------------------------- Most prenatal screening programs are not built to classify fetal uterine anomalies in detail, but boards love the embryologic linkage. Keep the genitourinary pairing in mind: ASRM notes strong associations between some Müllerian anomalies and renal anomalies, especially Müllerian agenesis and unilateral obstructed anomalies. So when a renal or urinary tract anomaly appears in the broader reproductive-tract context, think beyond a single organ and plan cross-system follow-up. That habit helps later when the patient presents with primary amenorrhea, cyclic pain, or an obstructive anomaly in adolescence. [\[7\]](#cite-7 "Reference [7]") Key Takeaways ------------- - **cfDNA screens for common aneuploidies; it does not diagnose them and it does not replace the anatomy scan.** [\[2\]](#cite-2 "Reference [2]") - **Structural anomalies and chromosomal anomalies overlap, but they are not the same problem.** Treat major defects differently from isolated soft markers. [\[3\]](#cite-3 "Reference [3]") - **Use timing conceptually:** early scan at 11-14 weeks for dating, NT, and early anatomy; routine detailed anatomy at 18-22 weeks, with some systems extending to about 24 weeks. [\[4\]](#cite-4 "Reference [4]") - **Refer early** for enlarged NT, any definite anomaly, abnormal screen plus abnormal imaging, or incomplete/concerning anatomy. [\[5\]](#cite-5 "Reference [5]") - **For Müllerian topics, always think renal associations.** Embryology is clinically useful only if it changes what else you look for. [\[7\]](#cite-7 "Reference [7]") Conclusion ---------- The high-yield approach is not to memorize every anomaly. It is to recognize what each screening tool can and cannot do, use the right scan window, and escalate quickly when findings cross the line from screening to diagnosis. That is how you avoid the classic board mistake and the real clinical one. [\[1\]](#cite-1 "Reference [1]") Frequently Asked Questions ---------------------------- ### Does a low-risk cfDNA result rule out major congenital anomalies? No. cfDNA is a screening test for common aneuploidies, not a structural survey, so patients still need second-trimester ultrasound assessment. [\[2\]](#cite-2 "Reference [2]") ### What should I do if the NT is enlarged at 11 to 14 weeks? Offer genetic counseling and diagnostic testing, and arrange comprehensive ultrasound follow-up because enlarged NT is linked to chromosomal and structural abnormalities. [\[5\]](#cite-5 "Reference [5]") ### If I find one isolated soft marker after negative cfDNA, do I need amniocentesis? Usually not for aneuploidy alone. SMFM recommends against diagnostic testing solely for many isolated soft markers after negative serum or cfDNA screening. [\[3\]](#cite-3 "Reference [3]") ### Why do renal findings matter in a curriculum block about Müllerian anomalies? Because some Müllerian anomalies are strongly associated with renal anomalies, so reproductive tract anomalies should trigger cross-system thinking and follow-up imaging. [\[7\]](#cite-7 "Reference [7]") References (7) ------------------ 1. 1. [ ACOG. Ultrasound Exams FAQ. Last reviewed October 2025. ](https://www.acog.org/womens-health/faqs/ultrasound-exams) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ ACOG. Screening for Fetal Chromosomal Abnormalities. Practice Advisory, January 2026. ](https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2026/01/screening-for-fetal-chromosomal-abnormalities) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ SMFM Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester. ](https://publications.smfm.org/publications/394-society-for-maternal-fetal-medicine-consult-series-57/) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ ISUOG Practice Guidelines (updated): performance of 11–14-week ultrasound scan. Ultrasound Obstet Gynecol. 2023. ](https://isuog.org/static/a8d6dee2-38d8-4d66-8be3929af48e8369/Updated-ISUOG-Practice-Guidelines-performance-of-11-14-week-ultrasound-scan.pdf) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ ACOG. Current Guidance on Prenatal Genetic Screening and Diagnostic Testing. ](https://www.acog.org/advocacy/policy-priorities/non-invasive-prenatal-testing/current-acog-guidance) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2022. ](https://www.isuog.org/static/4e2ed89e-fa8a-42c2-9c0929cd89cb58ff/ISUOG-Practice-Guidelines-routine-mid-trimester-fetal-ultrasound.pdf) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ ASRM Müllerian Anomalies Classification 2021. Fertility and Sterility. 2021. ](https://prod.asrm.org/practice-guidance/practice-committee-documents/asrm-mullerian-anomalies-classication-2021/) [↩](#cite-ref-7-1 "Back to text") Study pathway Build confidence in OB/GYN with focused practice -------------------------------------------------- - Labor & delivery + postpartum essentials - Gynecology, screening, and common procedures - Review weak topics and improve faster Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. Explore topics: [ # Board Review ](https://mdster.com/blog?tag=board-review) [ # Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ # Obstetrics ](https://mdster.com/blog?tag=obstetrics) [ # Prenatal Diagnosis ](https://mdster.com/blog?tag=prenatal-diagnosis) [ # Fetal Ultrasound ](https://mdster.com/blog?tag=fetal-ultrasound) [ # Müllerian Anomalies ](https://mdster.com/blog?tag=mullerian-anomalies) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Diagnostic Pathways and Staged Testing in Family Medicine 6 min read May 04, 2026 ](https://mdster.com/blog/diagnostic-pathways-and-staged-testing-in-family-medicine) [### Obstructive Shock: The Three Reversible Killers You Must Recognize 6 min read May 03, 2026 ](https://mdster.com/blog/obstructive-shock-the-three-reversible-killers-you-must-recognize) [### VUS Counseling in Pediatrics: How to Interpret Uncertain Variants 7 min read May 02, 2026 ](https://mdster.com/blog/vus-counseling-in-pediatrics-how-to-interpret-uncertain-variants) Related Posts ------------- [ ![Fragile X Syndrome in Pediatric Intellectual Disability: Case Discussion](https://mdster.com/storage/blog/images/fragile-x-syndrome-in-pediatric-intellectual-disability-case-discussion.jpg) Case Discussion ### Fragile X Syndrome in Pediatric Intellectual Disability: Case Discussion A 10-year-old boy with intellectual disability, macrocephaly, large ears, hypotonia, and maternal family history raises a classic question: when should pediatricians suspect Fragile X and test early? 6 min read 0 comments ](https://mdster.com/blog/fragile-x-syndrome-in-pediatric-intellectual-disability-case-discussion) [ ![Diagnostic Pathways and Staged Testing in Family Medicine](https://mdster.com/storage/blog/images/diagnostic-pathways-and-staged-testing-in-family-medicine.jpg) Medical Education ### Diagnostic Pathways and Staged Testing in Family Medicine A practical Family Medicine guide to staged testing: when to image, when to wait, how to manage incidentalomas, and how follow-up prevents misses. 6 min read 0 comments ](https://mdster.com/blog/diagnostic-pathways-and-staged-testing-in-family-medicine) [ ![Pediatric Trauma Airway and TBI: High-Stakes ED Case Discussion](https://mdster.com/storage/blog/images/pediatric-trauma-airway-and-tbi-high-stakes-ed-case-discussion.jpg) Case Discussion ### Pediatric Trauma Airway and TBI: High-Stakes ED Case Discussion A board-focused Emergency Medicine case discussion on pediatric trauma airway management, severe TBI ventilation, occult hemorrhagic shock, cervical spine precautions, and the limits of PECARN. 4 min read 0 comments ](https://mdster.com/blog/pediatric-trauma-airway-and-tbi-high-stakes-ed-case-discussion) [ ![Obstructive Shock: The Three Reversible Killers You Must Recognize](https://mdster.com/storage/blog/images/obstructive-shock-the-three-reversible-killers-you-must-recognize.jpg) Medical Education ### Obstructive Shock: The Three Reversible Killers You Must Recognize A focused, board-relevant review of obstructive shock for Internal Medicine, emphasizing bedside recognition and immediate management of tamponade, massive PE, and tension pneumothorax. 6 min read 0 comments ](https://mdster.com/blog/obstructive-shock-the-three-reversible-killers-you-must-recognize) [ ![VUS Counseling in Pediatrics: How to Interpret Uncertain Variants](https://mdster.com/storage/blog/images/vus-counseling-in-pediatrics-how-to-interpret-uncertain-variants.jpg) Medical Education ### VUS Counseling in Pediatrics: How to Interpret Uncertain Variants Learn how to interpret and counsel on VUS results in pediatric genetics using the ACMG framework, segregation analysis, de novo evidence, and structured follow-up. 7 min read 0 comments ](https://mdster.com/blog/vus-counseling-in-pediatrics-how-to-interpret-uncertain-variants) [ ![Ectopic Pregnancy Case Discussion: PUL, β-hCG, and Management](https://mdster.com/storage/blog/images/ectopic-pregnancy-case-discussion-pul-v-hcg-and-management.jpg) Case Discussion ### Ectopic Pregnancy Case Discussion: PUL, β-hCG, and Management A board-style case discussion on pregnancy of unknown location, serial β-hCG trends, ultrasound clues, methotrexate selection, rupture, and anti-D after ectopic pregnancy. 2 min read 0 comments ](https://mdster.com/blog/ectopic-pregnancy-case-discussion-pul-v-hcg-and-management) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept